Texas A&M cited potential foreign interference when explaining why it shut down a jointly run modeling laboratory.

After lobbying efforts from lawmakers and science advisors, the new, DARPA-like biomedical research agency will be a part of the National Institutes of Health, but its director will report directly to the secretary of Health and Human Services.

A narrow Senate vote ends a 13-month period during which the agency has lacked a permanent commissioner.

The cardiologist was briefly the FDA Commissioner in the Obama Administration, and now has a second chance to act on plans he tried to implement during his first tenure.

The legislation, which now heads to the House, aims to ensure the country can compete with China technologically by supporting research and development over the next five years.

See who’s on the ballot for House and Senate seats this year.

Administration officials have given contradictory statements about how COVID-19 will affect the US, and it is not clear who is leading the infectious disease response effort, critics say.

In the wake of reports of CRISPRed babies born in China, a bipartisan resolution “opposes the experiments that resulted in pregnancies using genome-edited human embryos.”

Information made public by US Senator Chuck Grassley reveals that a handful of allegations have recently been referred to federal investigators.

The Democrats’ takeover of the House inspires hope for science-based policies, but voters struck down several ballot initiatives to counteract climate change.

The midterm elections flip several House seats in favor of Democratic candidates with STEM backgrounds.

Opponents of the proposal call the changes a “wildlife extinction package.”

Alzheimer’s disease will receive $2.3 billion, the biggest chunk of change devoted to one of the NIH’s various interests.

A pesticide industry leader, Hutchins was formerly president of the Entomological Society of America.

NASA, NSF, and NIH are expected to receive higher financial backing for the 2019 fiscal year, going above and beyond the President’s proposed budget.  

The proposed spending increase in the draft bill is more generous than that in the House version.

The legislation removes restrictions for seriously ill patients to access experimental treatments that have not received FDA approval.

Price was asked about alleged conflicts of interest, whether he supports Medicare negotiating drug prices, and how he intends to replace the Affordable Care Act.

US government contemplates public health funding; World Health Organization advises summer Olympics attendees